Wantai Biotechnology's announcement on holding a performance briefing for the third quarter of 2025
Securities code: 603392 Securities abbreviation: Wantai Biotechnology Announcement number: 2025-053
Beijing Wantai Biopharmaceutical Co., Ltd.
Announcement on Convening the Third Quarter 2025 Results Briefing
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: November 11, 2025 (Tuesday) 11:00-12:00 am
Meeting location: Shanghai Stock Exchange Roadshow Center (Website: https://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the Shanghai Securities Roadshow Center website before 16:00 on November 4, 2025 (Tuesday) to November 10 (Monday) and click on the "Question Pre-Solicitation" column or ask questions through the company's email [email protected]. The company will answer questions of common concern to investors at the briefing.
Beijing Wantai Biopharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has released the company's 2025 third quarter report on October 30, 2025. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2025 third quarter operating results and financial status, the company plans to hold a 2025 third quarter performance briefing on November 11, 2025 at 11:00-12:00 am to communicate on issues of concern to investors.
1. Type of briefing session
This performance briefing will be held through online interaction. The company will interact and communicate with investors on the specific conditions of operating results and financial indicators in the third quarter of 2025, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: 11:00-12:00 am on November 11, 2025
(2) Meeting location: Shanghai Stock Exchange Roadshow Center
(Website: https://roadshow.sseinfo.com/)
(3) Meeting method: Shanghai Securities Roadshow Center online interaction
3. Participants
General Manager: Ms. JIANG ZHIMING
Independent Director: Mr. Cui Xuanlin
Financial Director: Mr. Lu Yun
Secretary of the Board of Directors: Mr. Yu Tao
4. How to participate as an investor
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) via the Internet from 11:00-12:00 a.m. on November 11, 2025 (Tuesday) to participate in this performance briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log in to the home page of the Shanghai Stock Exchange Roadshow Center website from November 4, 2025 (Tuesday) to November 10 (Monday) before 16:00, and click on the "Ask a Question Pre-Solicitation" column Project (https://roadshow.sseinfo.com/preCallQa), according to the event time, select this event or ask the company questions through the company’s email [email protected]. The company will answer questions of common concern to investors at the briefing meeting.
5. Contact person and consultation method
Contact person: Zhao Shuling
Tel: 010-59528820
Email: [email protected]
6. Other matters
After this investor briefing is held, investors can check the status and main content of this investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/). Announcement is hereby made.
Board of Directors of Beijing Wantai Biopharmaceutical Co., Ltd.
October 30, 2025